Jeil Pharmaceutical Co., Ltd. - Product Pipeline Review - 2016

Published: Aug, 2016 | Pages: 46 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Jeil Pharmaceutical Co., Ltd. - Product Pipeline Review - 2016

Summary

Global Markets Direct's, 'Jeil Pharmaceutical Co., Ltd. - Product Pipeline Review - 2016', provides an overview of the Jeil Pharmaceutical Co., Ltd.'s pharmaceutical research and development focus. 

The report provides comprehensive information on the therapeutics under development by Jeil Pharmaceutical Co., Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Jeil Pharmaceutical Co., Ltd.
- The report provides overview of Jeil Pharmaceutical Co., Ltd. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities 
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages 
- The report assesses Jeil Pharmaceutical Co., Ltd.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type 
- The report features Jeil Pharmaceutical Co., Ltd.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons To Buy

- Evaluate Jeil Pharmaceutical Co., Ltd.'s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage 
- Identify and understand important and diverse types of therapeutics under development for Jeil Pharmaceutical Co., Ltd.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Jeil Pharmaceutical Co., Ltd.'s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

 Table of Contents

Table of Contents 2
List of Tables 5
List of Figures 5
Jeil Pharmaceutical Co., Ltd. Snapshot 6
Jeil Pharmaceutical Co., Ltd. Overview 6
Key Information 6
Key Facts 6
Jeil Pharmaceutical Co., Ltd. - Research and Development Overview 7
Key Therapeutic Areas 7
Jeil Pharmaceutical Co., Ltd. - Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products - Monotherapy 11
Pipeline Products - Combination Treatment Modalities 12
Jeil Pharmaceutical Co., Ltd. - Pipeline Products Glance 13
Jeil Pharmaceutical Co., Ltd. - Late Stage Pipeline Products 13
Phase III Products/Combination Treatment Modalities 13
Jeil Pharmaceutical Co., Ltd. - Clinical Stage Pipeline Products 14
Phase I Products/Combination Treatment Modalities 14
Jeil Pharmaceutical Co., Ltd. - Early Stage Pipeline Products 15
Preclinical Products/Combination Treatment Modalities 15
Discovery Products/Combination Treatment Modalities 16
Jeil Pharmaceutical Co., Ltd. - Drug Profiles 17
(solifenacin succinate + tamsulosin hydrochloride) 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
JLP-1401 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
metformin hydrochloride + rosuvastatin calcium 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
JJP-1305 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
JPI-289 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
JGK-263 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
JLP-1601 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
JLP-1604 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
JP-1366 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
JP-2266 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
JPI-547 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
Small Molecule for Degenerative Arthritis 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
Small Molecule for Hypertriglyceridaemia 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
Stem Cell Therapy for Parkinson's Disease and Age-Related Macular Degeneration 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
JLP-1602 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
JLP-1603 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
Small Molecule to Inhibit FLT3 for Acute Myeloid Leukemia 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
Small Molecules for Neuropathic Pain 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
Jeil Pharmaceutical Co., Ltd. - Pipeline Analysis 35
Jeil Pharmaceutical Co., Ltd. - Pipeline Products by Target 35
Jeil Pharmaceutical Co., Ltd. - Pipeline Products by Route of Administration 37
Jeil Pharmaceutical Co., Ltd. - Pipeline Products by Molecule Type 38
Jeil Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action 39
Jeil Pharmaceutical Co., Ltd. - Recent Pipeline Updates 40
Jeil Pharmaceutical Co., Ltd. - Dormant Projects 41
Jeil Pharmaceutical Co., Ltd. - Company Statement 42
Jeil Pharmaceutical Co., Ltd. - Locations And Subsidiaries 43
Head Office 43
Other Locations & Subsidiaries 43
Appendix 45
Methodology 45
Coverage 45
Secondary Research 45
Primary Research 45
Expert Panel Validation 45
Contact Us 45
Disclaimer 46

List of Tables

Jeil Pharmaceutical Co., Ltd., Key Information 6
Jeil Pharmaceutical Co., Ltd., Key Facts 6
Jeil Pharmaceutical Co., Ltd. - Pipeline by Indication, 2016 8
Jeil Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2016 10
Jeil Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2016 11
Jeil Pharmaceutical Co., Ltd. - Combination Treatment Modalities in Pipeline, 2016 12
Jeil Pharmaceutical Co., Ltd. - Phase III, 2016 13
Jeil Pharmaceutical Co., Ltd. - Phase I, 2016 14
Jeil Pharmaceutical Co., Ltd. - Preclinical, 2016 15
Jeil Pharmaceutical Co., Ltd. - Discovery, 2016 16
Jeil Pharmaceutical Co., Ltd. - Pipeline by Target, 2016 36
Jeil Pharmaceutical Co., Ltd. - Pipeline by Route of Administration, 2016 37
Jeil Pharmaceutical Co., Ltd. - Pipeline by Molecule Type, 2016 38
Jeil Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action, 2016 39
Jeil Pharmaceutical Co., Ltd. - Recent Pipeline Updates, 2016 40
Jeil Pharmaceutical Co., Ltd. - Dormant Developmental Projects,2016 41
Jeil Pharmaceutical Co., Ltd., Other Locations 43